Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
6.03
+0.08 (1.34%)
Sep 2, 2026, 3:04 PM CST
SHE:002872 Revenue
Tiansheng Pharmaceutical Group had revenue of 101.03M CNY in the quarter ending June 30, 2026, a decrease of -13.40%. This brings the company's revenue in the last twelve months to 514.89M, down -1.07% year-over-year. In the year 2025, Tiansheng Pharmaceutical Group had annual revenue of 514.09M, down -9.76%.
Revenue (ttm)
514.89M
Revenue Growth
-1.07%
P/S Ratio
3.67
Revenue / Employee
404.47K
Employees
1,273
Market Cap
1.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 514.09M | -55.63M | -9.76% |
| Dec 31, 2024 | 569.71M | -9.62M | -1.66% |
| Dec 31, 2023 | 579.33M | -27.66M | -4.56% |
| Jan 1, 2023 | 606.99M | -129.69M | -17.61% |
| Jan 1, 2022 | 736.69M | -466.06M | -38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.15B |
| Shandong Sito Bio-technology | 1.12B |
| Zhejiang East Asia Pharmaceutical | 990.47M |
| Guiyang Xintian Pharmaceutical | 723.26M |
| Jilin Jian Yisheng Pharmaceutical | 650.83M |
| Suzhou Fushilai Pharmaceutical | 394.29M |
| Cabio Biotech (Wuhan) | 313.99M |
| Jiangsu CoWin Biotech | 219.42M |